AC Immune publishes data showing diagnostic activity of a-syn PET tracer in MSA - Clinical Trials Arena
AC IMMUNE SA | S-GE
Treatments & preventive strategies for neurodegenerative diseases
AC Immune names new chief medical officer
AC Immune (ACIU) Surges 43% in the Past 3 Months: Here's Why
Who is AC Immune? A cutting-edge company with a robust pipeline
AC Immune's Robust Pipeline focused on neurodegenerative diseases
Morphomer® and SupraAntigen® | AC Immune's Technology Platforms
AC Immune acquires Parkinson's vaccine candidate
Precision medicine for neurodegenerative diseases | AC Immune SA
AC Immune (@AC_Immune_SA) / X
AC Immune (@AC_Immune_SA) / X
Press Release
AC Immune - AnnualReports.com
AC Immune wins $500K to advance ALS diagnostic efforts | ALS News Today
AC Immune ACIU Q4 2022 Earnings Presentation - YouTube
Using @RISK and PrecisionTree to Shape the Future of Drug Development in Neurodegenerative Diseases - Lumivero
Early data from AC Immune Alzheimer's vaccine suggests response
AC Immune | LinkedIn
AC Immune: Dementia-Focused Swiss Biotech With A Sad History Of Failures (NASDAQ:ACIU) | Seeking Alpha
AC Immune (@AC_Immune_SA) / X
AC Immune Could Reload On Upcoming Readout (NASDAQ:ACIU) | Seeking Alpha
AC Immune erhält FDA Fast Track Designation für Anti-Amyloid-Beta-Impfung
Dr. Madiha Derouazi becomes AC Immune's CSO - BioAlps
AC Immune SA (NASDAQ:ACIU) Short Interest Update - MarketBeat
AC Immune (ACIU) Surges 43% in the Past 3 Months: Here's Why
AC Immune | LinkedIn
